Sepracor Inc. of Marlborough, Mass., named to its board ofdirectors Keith Mansford, chairman of the biopharmaceuticaldivision of Howard Fischer Associates.

James Poser was named vice president, research anddevelopment at Osteotech Inc. of Shrewsbury N.J. He wastechnical director for Intermedics Orthopaedics Inc.

Anergen Inc. of Redwood City, Calif., named Jeffrey Winkelhakevice president, product development, and promoted SomeshSharma to vice president, research, and chief scientific officerfrom VP, research. Winkelhake was director, programmanagement, at Cytel Corp.

Leonard Jacob was promoted to executive vice president andchief operating officer at Magainin Pharmaceuticals Inc. ofPlymouth Meeting, Pa. He had been the company's executivevice president of research and development.

Life Technologies Inc. of Gaithersburg, Md., appointed K.Grahame Walker chairman of the board of directors.

Alan Timmins has been appointed chief financial officer atAntivirals Inc. of Portland, Ore. Timmins was a senior managerin the San Francisco office of Price Waterhouse.

Alain Massot has been named as senior vice president,international, at PerSeptive Biosystems Inc. of Cambridge,Mass. Massot had been corporate vice president for marketingat Millipore Corp.

Harry Snyder joined BioCryst Pharmaceuticals Inc. ofBirmingham, Ala. as executive director of clinical development.Snyder was vice president of research at Imre Corp.

Biogen Inc. of Cambridge, Mass., appointed Joseph Davie vicepresident, research. Davie joins Biogen from G.D. Searle & Co.where he was corporate senior vice president for science andtechnology.

(c) 1997 American Health Consultants. All rights reserved.